Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study

<p>Abstract</p> <p>Background</p> <p>Tartrate-resistant acid phosphatase (TRAP) is a metalloprotein enzyme that belongs to the acid phosphatases and is known to be expressed by osteoclasts. It has already been investigated as a marker of bone metastases in cancer patien...

Full description

Bibliographic Details
Main Authors: Eck M, Krockenberger M, Kapp M, Rieger L, Honig A, Dietl J, Kämmerer U
Format: Article
Language:English
Published: BMC 2006-07-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/6/199
_version_ 1828256094434099200
author Eck M
Krockenberger M
Kapp M
Rieger L
Honig A
Dietl J
Kämmerer U
author_facet Eck M
Krockenberger M
Kapp M
Rieger L
Honig A
Dietl J
Kämmerer U
author_sort Eck M
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Tartrate-resistant acid phosphatase (TRAP) is a metalloprotein enzyme that belongs to the acid phosphatases and is known to be expressed by osteoclasts. It has already been investigated as a marker of bone metastases in cancer patients. In this study, which examined the value of serum TRAP concentrations as a marker of bone disease in breast cancer patients, we observed high concentrations of TRAP even in patients without bone metastases. To elucidate this phenomenon, we examined the expression of TRAP in breast cancer cells and the cells of several other malignancies.</p> <p>Methods</p> <p>TRAP concentrations in the serum of tumor patients were determined by ELISA. The expression of TRAP in breast, ovarian, and cervical cancer and malignant melanoma was analyzed by immunohistochemistry. RT-PCR and immunocytology were used to evaluate TRAP expression in cultured tumor cells.</p> <p>Results</p> <p>A marked increase in serum TRAP concentrations was observed in patients with breast and ovarian cancer, regardless of the presence or absence of bone disease. TRAP expression was found in breast and ovarian cancers and malignant melanoma, while cervical cancer showed only minimal expression of TRAP. Expression of TRAP was absent in benign tissue or was much less marked than in the corresponding malignant tissue. TRAP expression was also demonstrated in cultured primary cancer cells and in commercially available cell lines.</p> <p>Conclusion</p> <p>Overexpression of TRAP was detected in the cells of various different tumors. TRAP might be useful as a marker of progression of malignant disease. It could also be a potential target for future cancer therapies.</p>
first_indexed 2024-04-13T02:23:14Z
format Article
id doaj.art-aa6d81af633147efb1ee43b82b0c0272
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-13T02:23:14Z
publishDate 2006-07-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-aa6d81af633147efb1ee43b82b0c02722022-12-22T03:06:52ZengBMCBMC Cancer1471-24072006-07-016119910.1186/1471-2407-6-199Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational studyEck MKrockenberger MKapp MRieger LHonig ADietl JKämmerer U<p>Abstract</p> <p>Background</p> <p>Tartrate-resistant acid phosphatase (TRAP) is a metalloprotein enzyme that belongs to the acid phosphatases and is known to be expressed by osteoclasts. It has already been investigated as a marker of bone metastases in cancer patients. In this study, which examined the value of serum TRAP concentrations as a marker of bone disease in breast cancer patients, we observed high concentrations of TRAP even in patients without bone metastases. To elucidate this phenomenon, we examined the expression of TRAP in breast cancer cells and the cells of several other malignancies.</p> <p>Methods</p> <p>TRAP concentrations in the serum of tumor patients were determined by ELISA. The expression of TRAP in breast, ovarian, and cervical cancer and malignant melanoma was analyzed by immunohistochemistry. RT-PCR and immunocytology were used to evaluate TRAP expression in cultured tumor cells.</p> <p>Results</p> <p>A marked increase in serum TRAP concentrations was observed in patients with breast and ovarian cancer, regardless of the presence or absence of bone disease. TRAP expression was found in breast and ovarian cancers and malignant melanoma, while cervical cancer showed only minimal expression of TRAP. Expression of TRAP was absent in benign tissue or was much less marked than in the corresponding malignant tissue. TRAP expression was also demonstrated in cultured primary cancer cells and in commercially available cell lines.</p> <p>Conclusion</p> <p>Overexpression of TRAP was detected in the cells of various different tumors. TRAP might be useful as a marker of progression of malignant disease. It could also be a potential target for future cancer therapies.</p>http://www.biomedcentral.com/1471-2407/6/199
spellingShingle Eck M
Krockenberger M
Kapp M
Rieger L
Honig A
Dietl J
Kämmerer U
Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
BMC Cancer
title Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
title_full Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
title_fullStr Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
title_full_unstemmed Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
title_short Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study
title_sort increased tartrate resistant acid phosphatase trap expression in malignant breast ovarian and melanoma tissue an investigational study
url http://www.biomedcentral.com/1471-2407/6/199
work_keys_str_mv AT eckm increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT krockenbergerm increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT kappm increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT riegerl increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT honiga increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT dietlj increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy
AT kammereru increasedtartrateresistantacidphosphatasetrapexpressioninmalignantbreastovarianandmelanomatissueaninvestigationalstudy